Koss (KOSS)
(Delayed Data from NSDQ)
$7.04 USD
-0.10 (-1.40%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $7.00 -0.04 (-0.57%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.04 USD
-0.10 (-1.40%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $7.00 -0.04 (-0.57%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
KOSS Q1 Loss Widens Y/Y Amid U.S. Sales Decline and Cost Pressures
by Zacks Equity Research
KOSS incurs a wider loss year over year in fiscal Q1 2025, with sales down 5.1% due to weaker U.S. demand. Growth in Europe and DTC channels help offset declines, but higher SG&A costs increase losses.
KOSS Q4 Loss Narrows Y/Y, Revenue Declines on Weak Export Sales
by Zacks Equity Research
Koss incurs a narrower Q4 loss along with a 5.9% revenue drop, impacted by weaker export sales in Europe and Asia, despite growth in education and DTC sectors.
Zacks Initiates Coverage of KOSS With Underperform Recommendation
by Debasmita Chatterjee
Discover why Zacks has given KOSS an "Underperform" rating, being the first on Wall Street to initiate coverage on the stock. Explore the company's financial challenges, competitive pressures and operational risks, balanced by its strong cash reserves and focus on innovation.
The Zacks Analyst Blog Highlights Microsoft, Eli Lilly, Costco and Koss
by Zacks Equity Research
Microsoft, Eli Lilly, Costco and Koss are included in this Analyst Blog.
Top Research Reports for Microsoft, Eli Lilly & Costco
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).
AMC & r/wallstreetbets: A Market Moving Combo
by Daniel Laboe
'Meme stocks' are back in fashion, and AMC is stealing the spotlight with a nearly 200% rally in the past 5 days of trading.
Stock Market News for Feb 2, 2021
by Zacks Equity Research
US stocks ended sharply higher on Monday after speculative trading in a set of small, heavily traded companies last week saw markets recording their worst loss since October.
Stock Market News for Feb 1, 2021
by Zacks Equity Research
US stock markets closed sharply lower on Friday, recording the worst weekly decline in stocks since October, as speculative trading in a set of small, heavily traded companies, unsettled markets as a result of growing panic among traders.
Short-Squeeze Frenzy and Option Gamma Gearing
by Kevin Cook
It's not just high short-interest fueling the massive rallies, it's also about option market dynamics.